Roche MS drug Ocrevus wins European panel backing

ZURICH (Reuters) - Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for nearly $1 billion in sales in 2017 after winning U.S. regulators' go-ahead earlier this year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news